MENU
+Compare
MYGN
Stock ticker: NASDAQ
AS OF
Aug 7, 12:21 PM (EDT)
Price
$5.53
Change
-$0.14 (-2.47%)
Capitalization
1.93B

MYGN Myriad Genetics Forecast, Technical & Fundamental Analysis

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual’s risk of developing a disease... Show more

Industry: #Biotechnology
MYGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MYGN with price predictions
Aug 06, 2025

MYGN in downward trend: 10-day moving average moved below 50-day moving average on July 24, 2025

The 10-day moving average for MYGN crossed bearishly below the 50-day moving average on July 24, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MYGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MYGN broke above its upper Bollinger Band on August 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 65 cases where MYGN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 06, 2025. You may want to consider a long position or call options on MYGN as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MYGN just turned positive on August 06, 2025. Looking at past instances where MYGN's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

MYGN moved above its 50-day moving average on August 06, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MYGN advanced for three days, in of 307 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 190 cases where MYGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MYGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.460) is normal, around the industry mean (24.599). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (1.236) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.357) is also within normal values, averaging (43.219).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MYGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
MYGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MYGN is expected to report earnings to fall 88.80% to 0 cents per share on November 04

Myriad Genetics MYGN Stock Earnings Reports
Q3'25
Est.
$0.01
Q2'25
Beat
by $0.06
Q1'25
Beat
by $0.03
Q4'24
Est.
$0.03
Q3'24
Beat
by $0.04
The last earnings report on August 05 showed earnings per share of 5 cents, beating the estimate of 0 cents. With 632.36K shares outstanding, the current market capitalization sits at 1.93B.
A.I. Advisor
published General Information

General Information

a developer of therapeutic and predictive medicine products

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
320 Wakara Way
Phone
+1 801 584-3600
Employees
2700
Web
https://www.myriad.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLUTX27.74N/A
N/A
Fidelity Advisor Stk Selec Lg Cp Val M
TILVX27.17N/A
N/A
Nuveen Large Cap Value Idx R6
MMYAX8.25N/A
N/A
MassMutual Small Company Value A
MWEHX45.85N/A
N/A
MFS Global Equity R3
WRAAX13.68N/A
N/A
Wilmington Global Alpha Equities A

MYGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MYGN has been loosely correlated with WAT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if MYGN jumps, then WAT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYGN
1D Price
Change %
MYGN100%
+46.51%
WAT - MYGN
39%
Loosely correlated
-1.23%
ATEC - MYGN
34%
Loosely correlated
-0.91%
VCYT - MYGN
32%
Poorly correlated
-4.16%
AORT - MYGN
31%
Poorly correlated
+0.37%
MASI - MYGN
30%
Poorly correlated
-11.73%
More